Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07450625 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Collagendep in Reducing Vulvar Dryness in Patients With Lichen Sclerosus Treated With Fat Grafting

Study acronym: Collagendep
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 4, 2026 (before its estimated August 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
This randomized, interventional study evaluates the efficacy of Collagendep Pink Beauty, an oral nutritional supplement, in reducing vulvar dryness in women with Genital Lichen Sclerosus (VLS) who are undergoing fat grafting treatment. Lichen sclerosus is a chronic inflammatory condition that leads to tissue hardening, loss of elasticity, and significant symptoms such as itching, pain, and dryness, which severely impact functional and emotional well-being. While fat grafting is a recognized regenerative therapy for stabilizing the disease, this study investigates whether a 4-month course of bioactive collagen peptides and functional ingredients can further improve mucosal hydration and symptom relief compared to fat grafting alone.
Trial Details
NCT Number NCT07450625
Lead Sponsor San Gallicano Dermatological Institute IRCCS
Conditions
(from sponsor)
Vulvar Lichen Sclerosus, Vulvar Atrophy
Related terms Lichen Sclerosus et Atrophicus, Vulvar Lichen Sclerosus
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov